Celldex Therapeutics Inc.

NASDAQ: CLDX · Real-Time Price · USD
25.48
0.54 (2.17%)
At close: Aug 15, 2025, 3:59 PM
25.50
0.08%
After-hours: Aug 15, 2025, 04:54 PM EDT

Celldex Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
28.36M 34.81M 29.43M 39.14M
Short-Term Investments
696.92M 388.78M 275.52M 369.11M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
9.75M 107K n/a n/a
Receivables
700K 2.63M 347K 172K
Inventory
n/a n/a -347K -172K
Other Current Assets
21.18M 5.47M 12.74M 172K
Total Current Assets
747.16M 431.69M 317.69M 410.84M
Property-Plant & Equipment
8.24M 6.64M 3.75M 3.55M
Goodwill & Intangibles
27.19M 27.19M 31.3M 30.26M
Total Long-Term Assets
45.18M 33.93M 35.04M 33.81M
Total Assets
792.34M 465.63M 352.74M 444.65M
Account Payables
3.27M 3.49M 3.34M 1.23M
Deferred Revenue
n/a n/a n/a 12M
Short-Term Debt
1.45M 1.61M 1.45M 1.75M
Other Current Liabilities
33.33M 2.37M 4.85M -12.19M
Total Current Liabilities
39.5M 31.13M 18.61M 16.53M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
3.47M 4.4M 5.33M 7.35M
Total Long-Term Liabilities
5.83M 5.33M 7.92M 8.65M
Total Liabilities
45.34M 36.46M 26.53M 25.18M
Total Debt
3.81M 2.54M 4.03M 3.04M
Common Stock
66K 56K 47K 47K
Retained Earnings
-1.56B -1.4B -1.26B -1.14B
Comprehensive Income
3.31M 3.31M 1.26M 1.89M
Shareholders Equity
747M 429.17M 326.2M 419.48M
Total Investments
696.92M 388.78M 275.52M 369.11M